pentoxifylline has been researched along with Thrombopenia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline-induced thrombocytopenia is rare, and information is lacking about its presentation." | 7.81 | Pentoxifylline-Induced Thrombocytopenia: A Case Report. ( Sklar, GE; Tan, MW, 2015) |
| "Although thrombocytopenia is a recognized side effect of interferon therapy, this very dangerous complication has not been previously reported using interferon for the Kasabach-Merritt syndrome." | 5.33 | Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline. ( de la Hunt, MN, 2006) |
| "Pentoxifylline-induced thrombocytopenia is rare, and information is lacking about its presentation." | 3.81 | Pentoxifylline-Induced Thrombocytopenia: A Case Report. ( Sklar, GE; Tan, MW, 2015) |
| " Thirty-five previously treated advanced breast cancer patients received 70 cycles (median, 2 cycles/patient; range, 1-6) of 1600 mg of oral sustained release pentoxifylline every 8 h for 4 doses in combination with escalating doses of i." | 2.68 | Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer. ( Cap, B; Dezube, BJ; Hayes, DF; Henderson, IC; Shapiro, CL; Tretyakov, O; Wright, J, 1995) |
| "Although thrombocytopenia is a recognized side effect of interferon therapy, this very dangerous complication has not been previously reported using interferon for the Kasabach-Merritt syndrome." | 1.33 | Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline. ( de la Hunt, MN, 2006) |
| "Kasabach-Merritt syndrome is a combination of thrombocytopenia, intravascular coagulation, and a rapid increase in the size of an angioma." | 1.28 | [Kasabach-Merritt syndrome in children]. ( Andry, P; Bodemer, C; Brunelle, F; de Prost, Y; Hubert, P; Nihoul-Fékété, C; Sebag, G; Teillac-Hamel, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, MW | 1 |
| Sklar, GE | 1 |
| de la Hunt, MN | 1 |
| Acharya, S | 1 |
| Nair, BC | 1 |
| Shapiro, CL | 1 |
| Dezube, BJ | 1 |
| Tretyakov, O | 1 |
| Wright, J | 1 |
| Cap, B | 1 |
| Henderson, IC | 1 |
| Hayes, DF | 1 |
| Teillac-Hamel, D | 1 |
| Andry, P | 1 |
| Bodemer, C | 2 |
| Hubert, P | 1 |
| Sebag, G | 1 |
| Brunelle, F | 1 |
| Nihoul-Fékété, C | 2 |
| de Prost, Y | 2 |
| Teillac, D | 1 |
| Enjolras, O | 1 |
| de Prost, D | 1 |
1 trial available for pentoxifylline and Thrombopenia
| Article | Year |
|---|---|
Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Dose-Response Relationship, Dr | 1995 |
5 other studies available for pentoxifylline and Thrombopenia
| Article | Year |
|---|---|
Pentoxifylline-Induced Thrombocytopenia: A Case Report.
Topics: Aged; Humans; Male; Pentoxifylline; Platelet Aggregation Inhibitors; Thrombocytopenia | 2015 |
Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline.
Topics: Angiogenesis Inhibitors; Female; Hemangioma, Capillary; Hematologic Agents; Humans; Infant; Interfer | 2006 |
Pentoxifylline-induced thrombocytopenia.
Topics: Blood Platelets; Humans; Pentoxifylline; Platelet Count; Thrombocytopenia; Varicose Ulcer; Vasodilat | 1997 |
[Kasabach-Merritt syndrome in children].
Topics: Aspirin; Child, Preschool; Disseminated Intravascular Coagulation; Embolization, Therapeutic; Hemang | 1992 |
Successful treatment of Kasabach-Merritt syndrome with pentoxifylline.
Topics: Disseminated Intravascular Coagulation; Female; Forearm; Hemangioma; Humans; Infant; Pentoxifylline; | 1991 |